Daniel Lee
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,807 | 71 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SK Life Science, Inc. | $288.83 | 10 | $0 (2024) |
| UCB, Inc. | $231.30 | 11 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $178.78 | 8 | $0 (2024) |
| Jazz Pharmaceuticals Inc. | $139.29 | 2 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $134.97 | 6 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $130.35 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $111.19 | 5 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $74.06 | 3 | $0 (2024) |
| Genentech USA, Inc. | $71.99 | 3 | $0 (2024) |
| ARGENX US, INC. | $63.63 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,183 | 46 | UCB, Inc. ($184.87) |
| 2023 | $582.88 | 22 | Jazz Pharmaceuticals Inc. ($139.29) |
| 2022 | $41.62 | 3 | MITSUBISHI TANABE PHARMA AMERICA, INC. ($41.62) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $130.35 | General |
| Category: Central Nervous System | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Neurology | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Neurology | ||||||
| 10/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Neurology | ||||||
| 10/07/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: RETT SYNDROME | ||||||
| 10/01/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Neurology | ||||||
| 09/30/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $34.09 | General |
| Category: Neurology | ||||||
| 09/27/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 09/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Neuropsychiatry | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Neurology | ||||||
| 09/23/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Neurology | ||||||
| 09/23/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $0.72 | General |
| Category: Neurology | ||||||
| 09/20/2024 | Azurity Pharmaceuticals, Inc. | ZONISADE (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 09/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Neurology | ||||||
| 09/13/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Neurology | ||||||
| 09/10/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: Neurology | ||||||
| 09/09/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/09/2024 | Azurity Pharmaceuticals, Inc. | ZONISADE (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 08/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Immunology and Neurology | ||||||
| 07/29/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $33.40 | General |
| 06/28/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Neurology | ||||||
About Daniel Lee
Daniel Lee is a Student in an Organized Health Care Education/Training Program healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2021. The National Provider Identifier (NPI) number assigned to this provider is 1811566532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Lee has received a total of $1,807 in payments from pharmaceutical and medical device companies, with $1,183 received in 2024. These payments were reported across 71 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,807).
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Neurology
- Location Mobile, AL
- Active Since 06/18/2021
- Last Updated 10/06/2023
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1811566532
Products in Payments
- EPIDIOLEX (Drug) $139.29
- Austedo XR (Drug) $130.35
- ULTOMIRIS (Biological) $118.54
- NUPLAZID (Drug) $115.16
- KESIMPTA (Drug) $111.19
- INGREZZA (Drug) $74.06
- Briviact (Drug) $72.63
- Ocrevus (Biological) $71.99
- RADICAVA (Drug) $61.63
- SOLIRIS (Biological) $60.24
- Fintepla (Drug) $49.59
- ZONISADE (Drug) $48.64
- Nayzilam (Drug) $47.76
- Gamunex-C (Biological) $44.74
- Zilbrysq (Drug) $43.18
- UBRELVY (Drug) $42.13
- HYQVIA (Biological) $40.24
- VYVGART (Drug) $36.02
- REXULTI (Drug) $28.86
- VYVGART HYTRULO (Drug) $27.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Mobile
Dr. William Kilgo, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $168,470
Dr. William Sonnier, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $130,244
Mr. Thomas Turnage, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $80,392
Mrs. Ashleigh Butts-Wilkerson, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $49,440
Dr. Ahmed Subahi, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $36,917
Dr. Brian Wood, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $24,083